ANI Pharmaceuticals, Inc.
ANIP
$75.42
-$1.12-1.46%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 294.72M | 271.47M | 223.52M | 155.19M | 151.17M |
| Total Receivables | 281.08M | 252.62M | 225.65M | 220.33M | 221.73M |
| Inventory | 143.07M | 146.48M | 138.32M | 137.41M | 136.78M |
| Prepaid Expenses | 22.99M | 18.35M | 14.81M | 23.13M | 17.98M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.26M | 9.49M | 336.00K | 234.00K | 805.00K |
| Total Current Assets | 753.12M | 698.40M | 602.63M | 536.29M | 528.46M |
|
|
|||||
| Total Current Assets | 753.12M | 698.40M | 602.63M | 536.29M | 528.46M |
| Net Property, Plant & Equipment | 62.48M | 63.56M | 59.25M | 58.18M | 56.86M |
| Long-term Investments | 62.48M | 62.48M | 60.53M | 60.66M | 59.99M |
| Goodwill | 62.48M | 62.48M | 60.53M | 60.66M | 59.99M |
| Total Other Intangibles | 479.53M | 499.82M | 520.32M | 538.50M | 541.83M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 81.13M | 81.66M | 100.27M | 98.80M | 92.43M |
| Total Assets | 1.44B | 1.41B | 1.34B | 1.29B | 1.28B |
|
|
|||||
| Total Accounts Payable | 62.58M | 69.80M | 54.57M | 53.06M | 45.66M |
| Total Accrued Expenses | 144.32M | 135.45M | 116.59M | 80.68M | 92.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.30M | 15.24M | 13.22M | 11.19M | 9.17M |
| Total Finance Division Other Current Liabilities | 51.91M | 50.07M | 52.46M | 56.88M | 46.82M |
| Total Other Current Liabilities | 51.91M | 50.07M | 52.46M | 56.88M | 46.82M |
| Total Current Liabilities | 278.11M | 270.56M | 236.84M | 201.82M | 194.45M |
|
|
|||||
| Total Current Liabilities | 278.11M | 270.56M | 236.84M | 201.82M | 194.45M |
| Long-Term Debt | 599.77M | 605.07M | 608.35M | 611.63M | 614.92M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.22M | 11.27M | 6.70M | 7.02M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.55M | 15.44M | 29.52M | 28.49M | 46.57M |
| Total Liabilities | 899.65M | 902.34M | 881.39M | 848.96M | 855.94M |
|
|
|||||
| Common Stock & APIC | 596.04M | 586.23M | 541.90M | 531.06M | 519.66M |
| Retained Earnings | -23.10M | -50.59M | -76.86M | -85.00M | -100.28M |
| Treasury Stock & Other | -32.22M | -29.83M | -28.28M | -27.43M | -15.70M |
| Total Common Equity | 540.72M | 505.82M | 436.76M | 418.62M | 403.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 24.85M | 24.85M | 24.85M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 24.85M | 24.85M | 24.85M |
|
|
|||||
| Total Common Equity | 540.72M | 505.82M | 436.76M | 418.62M | 403.68M |
| Total Preferred Equity | -- | -- | 24.85M | 24.85M | 24.85M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 540.72M | 505.82M | 461.61M | 443.47M | 428.53M |
|
|
|||||